Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2005
03/10/2005WO2003072542A3 Interfacial biomaterials
03/10/2005WO2003027254A9 15625 receptor, a novel g-protein coupled receptor
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005US20050055746 Enhancing leaf protein concentration in plant via transformmation with vector comprising nucleotide sequences which code for serine and aspartate protease inhibitors; tissue engineering and enhancing animal feeds
03/10/2005US20050055735 Use of complement protein C3 and its derivatives in enhancing mammalian embryo development
03/10/2005US20050055734 Prenatal screening
03/10/2005US20050054843 Subtilisin comprising b-cell epitope for use in detergents, textile treatment, liquid soaps, cosmetics and contact lense cleaning solutions
03/10/2005US20050054828 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054823 Genes
03/10/2005US20050054820 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy
03/10/2005US20050054599 using gene expression to target, detection response to stress
03/10/2005US20050054595 Genetic engineering; gene expression of target agent
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054564 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
03/10/2005US20050054105 Expression vector comprising inverted terminal repeats for use as gene transfer tool in genetic engineering; genetic vaccines
03/10/2005US20050054103 Using enzyme inhibitor to prevent phosphatidylinositol 3-kinase (PI 3-kinase) activity and expand preferential cell populations; regenerative medicine; tissue engineering; immunotherapy
03/10/2005US20050054102 Culturing preferential stem cells and generating pancreatic beta cell tissues via transfection for use in treatment of diabetes, hyperglycemia, and/or impaired glucose tolerance; tissue engineering; regenerative medicine
03/10/2005US20050054101 Automated cell culture system and process
03/10/2005US20050054100 Methods for fibroblast differentiation
03/10/2005US20050054099 Matrix derived from whole organ
03/10/2005US20050054098 Chord tissue for use in repair of damaged heart, kidney, bone, cartilage, pancreas and/or liver tissue; regenerative medicine; tissue engineering
03/10/2005US20050054097 Expansion of stem cells; prevent cell differentiation , gene expression
03/10/2005US20050054096 Using monocytic stem cells to generate pluripotent blood, bone marrow and/or serous cavity derived mononuclear cells for use in treatment of liver, pancreatic and nervous tissue damages; regenerative medicine; tissue engineering
03/10/2005US20050054095 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
03/10/2005US20050054094 SPRR1A and axonal regeneration
03/10/2005US20050054093 Progenitor cell culture for use in regenerative medicine and treatment of heart, liver and pancreatic disorders; tissue engineering and repair
03/10/2005US20050054092 Process for making transplantable cardiomyocytes from human embryonic stem cells
03/10/2005US20050054091 Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
03/10/2005US20050054090 MHC class II antigen-presenting systems and methods for activating CD4cells
03/10/2005US20050054089 Malignant endothelial cell line and uses thereof in models for angiogenesis
03/10/2005US20050054073 Cytidine deaminase
03/10/2005US20050054050 Green fluorescent protein for use as diagnostic indicator of genic expression in transformed cells; genetic engineering
03/10/2005US20050054046 Evaluating safety, efficacy and biological properties of immunoglobulin receptors; immunotherapeutic agents
03/10/2005US20050054045 Novel G-protein coupled receptor
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054034 Polypeptide encoding by a polynucleotide; for detecting diseases; use in diagnosis and in identifying compounds that may be agonists, antagonists as biodrug treating diseases; host cell culturing
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053933 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof
03/10/2005US20050053925 Epitopes; immunoglobulins; hybridomas; diagnostic kits
03/10/2005US20050053924 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
03/10/2005US20050053920 Retrovirus from the HIV group and its use
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053912 Methods for inducing reversible stasis
03/10/2005US20050053910 Gene transfer composition and method
03/10/2005US20050053612 Nucleotide regulation of immune responses
03/10/2005US20050053610 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
03/10/2005US20050053608 Using monoclonal antibody/maytansine fusion as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy
03/10/2005US20050053588 Conversion of liver stem and progenitor cells to pancreatic functional cells
03/10/2005US20050053587 Genetically-engineered bone marrow stromal cells; expression vectors comprise promoter, internal ribosome entry site, marker sequence, and sequence encoding erythropoietin; improved biocompatbility; tissue repair; angiogenesis
03/10/2005US20050053586 Proliferation/differentiation inhibition; storage stability
03/10/2005US20050053585 Cell constructs cultured in vitro, preparation and uses
03/10/2005US20050051474 Reconstituting lyophillized erythrocytes with a solution of trehalose or another oligosaccharide solute having a concentration large enough to produce hyperosmotic pressure on the cell to transfer the solute from the solution into the cell
03/10/2005CA2553673A1 Method for determining embryo quality
03/10/2005CA2537509A1 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
03/10/2005CA2537403A1 In vitro generation of gabaergic neurons from embryonic stem cells and their use in the treatment of neurological disorders
03/10/2005CA2537161A1 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris)
03/10/2005CA2537151A1 Novel vector and utilization of the same
03/10/2005CA2537149A1 Follicular fluid for prolonged growth and survival of cells for cell therapies
03/10/2005CA2537099A1 Modulation of .beta.-catenin/tcf activated transcription
03/10/2005CA2536911A1 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor
03/10/2005CA2536909A1 Kidney derived stem cells and methods for their isolation, differentiation and use
03/10/2005CA2536868A1 Enhancing the circulating half-life of interleukin-2 proteins
03/10/2005CA2536831A1 Method of constructing offspring originating from frozen sperm stem cell
03/10/2005CA2536675A1 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method
03/10/2005CA2536599A1 Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
03/10/2005CA2536588A1 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
03/10/2005CA2536067A1 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
03/10/2005CA2535902A1 Uses of spatial configuration to modulate protein function
03/10/2005CA2535816A1 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
03/10/2005CA2535526A1 Laccases, nucleic acids encoding them and methods for making and using them
03/10/2005CA2532737A1 Method for the production of porous carbon-based molded bodies, and use thereof as cell culture carrier systems and culture systems
03/10/2005CA2525374A1 Delivery of compounds with rehydrated blood cells
03/09/2005EP1512749A2 DNA to be introduced into biogenic gene, gene introducing vector, cell, and method for introducing information into biogenic gene
03/09/2005EP1512739A1 Chrondrocyte therapeutic delivery system
03/09/2005EP1512696A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
03/09/2005EP1512695A1 Hypoallergenic polypeptides based on fish parvalbumin
03/09/2005EP1512014A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511864A2 Viral capsid assembly intermediates
03/09/2005EP1511853A2 Regulation of novel human asparagine-hydroxylases
03/09/2005EP1511846A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
03/09/2005EP1511839A1 Generation of neural stem cells from undifferentiated human embryonic stem cells
03/09/2005EP1511838A1 Methods of regulating differentiation in stem cells
03/09/2005EP1511837A1 Device for multiple simultaneous gene transfer
03/09/2005EP1511768A1 Immunogenic compositions
03/09/2005EP1511762A2 Detection of secreted polypeptides
03/09/2005EP1511520A2 Compositions and methods for the use of bcl-2 transfected neurons
03/09/2005EP1511515A1 Stimulation of hematopoiesis by ex vivo actived immune cells
03/09/2005EP1511506A1 Compositions and methods for preventing, treating and diagnosing diabetes
03/09/2005EP1511377A1 Sterilization, stabilization and preservation of functional biologics
03/09/2005EP1451295A4 Methods for mutating genes in cells and animals using insertional mutagenesis
03/09/2005EP1448053A4 Proliferation and differentiation of stem cells using extracellular matrix and other molecules
03/09/2005EP1237916B1 Ing2, an iaps associated cell cycle protein, compositions and methods of use
03/09/2005EP1233783B1 Hbv/hcv virus-like particle
03/09/2005EP1206225B1 In vitro repair of bone and/or cartilage defects
03/09/2005EP1115277A4 Novel method of regulating seed development in plants and genetic sequences therefor
03/09/2005EP1108026B1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
1 ... 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 ... 1827